Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis.
- Published in:
- 2011
- Publication type:
- Correction Notice
Works matching IS 09612033 AND DT 2011 AND VI 20 AND IP 13
Results: 18
1
2
The Systemic Lupus International Collaborating Clinics (SLICC) group – It was 20 years ago today.
- Published in:
- Lupus, 2011, v. 20, n. 13, p. 1426, doi. 10.1177/0961203311421501
- By:
- Publication type:
- Article
3
Role of reactive intermediates in the immunopathogenesis of the pristane-induced Balb/c model of lupus.
- Published in:
- Lupus, 2011, v. 20, n. 13, p. 1421, doi. 10.1177/0961203311418791
- By:
- Publication type:
- Article
4
1H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus.
- Published in:
- Lupus, 2011, v. 20, n. 13, p. 1411, doi. 10.1177/0961203311418707
- By:
- Publication type:
- Article
5
Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis.
- Published in:
- Lupus, 2011, v. 20, n. 13, p. 1404, doi. 10.1177/0961203311417033
- By:
- Publication type:
- Article
6
Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis.
- Published in:
- Lupus, 2011, v. 20, n. 13, p. 1345, doi. 10.1177/0961203311416694
- By:
- Publication type:
- Article
7
Discrepancies in glomerular and tubulointerstitial/vascular immune complex IgG subclasses in lupus nephritis.
- Published in:
- Lupus, 2011, v. 20, n. 13, p. 1396, doi. 10.1177/0961203311416533
- By:
- Publication type:
- Article
8
The effects of cyclophosphamide and mycophenolate on end-stage renal disease and death of lupus nephritis.
- Published in:
- Lupus, 2011, v. 20, n. 13, p. 1442, doi. 10.1177/0961203311416034
- By:
- Publication type:
- Article
9
Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis.
- Published in:
- Lupus, 2011, v. 20, n. 13, p. 1378, doi. 10.1177/0961203311415561
- By:
- Publication type:
- Article
10
Repeated brain conventional MRI and SPECT evaluation in systemic lupus erythematosus patients with and without neuropsychiatric involvement: a follow up study.
- Published in:
- Lupus, 2011, v. 20, n. 13, p. 1387, doi. 10.1177/0961203311415304
- By:
- Publication type:
- Article
11
Antiphospholipid antibodies in patients with purported ‘chronic Lyme disease’.
- Published in:
- Lupus, 2011, v. 20, n. 13, p. 1372, doi. 10.1177/0961203311414098
- By:
- Publication type:
- Article
12
Histone modifications and methyl-CpG-binding domain protein levels at the TNFSF7 (CD70) promoter in SLE CD4+ T cells.
- Published in:
- Lupus, 2011, v. 20, n. 13, p. 1365, doi. 10.1177/0961203311413412
- By:
- Publication type:
- Article
13
Brain diffuse large B-cell lymphoma in a systemic lupus erythematosus patient treated with immunosuppressive agents including mycophenolate mofetil.
- Published in:
- 2011
- By:
- Publication type:
- Letter
14
Two different clinical subsets of lupus hepatitis exist. Mimicking primary autoimmune liver diseases or part of their spectrum?
- Published in:
- 2011
- By:
- Publication type:
- Letter
15
Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome.
- Published in:
- Lupus, 2011, v. 20, n. 13, p. 1356, doi. 10.1177/0961203311411348
- By:
- Publication type:
- Article
16
Stevens–Johnson syndrome in a juvenile systemic lupus erythematosus patient.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
17
Spontaneous coronary artery dissection in the context of positive anticardiolipin antibodies and clinically undiagnosed systemic lupus erythematosus.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
18
Primary antiphospholipid antibody syndrome presenting with encephalopathy, psychosis and seizures.
- Published in:
- 2011
- By:
- Publication type:
- Case Study